ATPC and FORMEDIC Technologies Announce Strategic Collaboration to Launch LEGA, a Revolutionary Respiratory Care Device

September 30, 2024 11:45 PM

NASDAQ-listed AGAPE ATP Corporation ("ATPC"), is proud to announce a strategic collaboration with FORMEDIC Technologies Sdn. Bhd. ("FORMEDIC Technologies") to introduce LEGA, an electronic chest percussion device for respiratory care. This partnership marks a major advancement in respiratory health, as the two companies combine their strengths to address the growing demand for advanced respiratory solutions.LEGA, FORMEDIC's flagship product,...

Read more

Moderna and Cenra Healthcare Enter Joint Agreement to Promote Moderna’s mRNA Respiratory Vaccine Portfolio in Taiwan, Including COVID-19 Vaccines

September 30, 2024 8:00 PM

CAMBRIDGE, MA and TAIPEI, TAIWAN / ACCESSWIRE / September 30, 2024 / Moderna, Inc. (Nasdaq:MRNA) and Cenra Healthcare, the sales and marketing arm of Cenra Inc., today announced that the companies have entered into a joint agreement regarding the co-promotion of Moderna's mRNA respiratory vaccine portfolio in Taiwan, including Moderna's COVID-19 vaccine, Spikevax®.Under the agreement, Moderna will manufacture and distribute its mRNA respiratory...

Read more

Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities

September 30, 2024 5:48 PM

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / September 30, 2024 / Biophytis SA (Euronext Growth Paris:ALBPS) ("Biophytis" or the "Company"), a clinical-stage biotechnology company focused on developing treatments for age-related diseases, publishes today its financial results for the first half of 2024 and provides an update on the company's key achievements.Stanislas Veillet, CEO of Biophytis, commented:"We are particularly pleased with the...

Read more

Inside the Life of Johanna Altman, Matt Altman’s Wife: Blending Real Estate Mastery with Family Values

September 30, 2024 5:15 PM

Johanna Altman, a pivotal figure in Los Angeles' real estate market and known to many as "Matt Altman's Wife," recently shared profound insights in an exclusive interview that delves into her professional journey and personal life. This compelling discussion highlights how her unique background and approach have shaped her success in both realms.Johanna, the owner and broker at Grid Properties, is celebrated not just for her professional...

Read more

Ascelia Pharma Finalizes Rights Issue with Runway Extended to Late 2025

September 30, 2024 11:15 AM

Ascelia Pharma AB (publ) (STO:ACE), a biotech focused on improving the life of people living with rare cancer conditions, today announced the finalization of the rights issue of units (the "Rights Issue") announced on 10 July 2024, including the conversion of paid subscribed units (BTU) to ordinary shares and warrants series TO 1. With the fully subscribed Rights Issue, the cash runway of the Company is extended to late 2025.The Rights Issue...

Read more

COVID's 'Hidden Figure' Addresses 'Techanthropy' and Small Business Challenges in New Product and National Column

September 30, 2024 10:30 AM

BALTIMORE, MD / ACCESSWIRE / September 30, 2024 / Tiffany Tate, CEO of VAULT Technologies and a recognized leader in technology and public health innovation, will be contributing content on Fast Company, a national publication with a combined readership of more than 11 million. Dubbed a "Hidden Figure" by International Business Times for her groundbreaking - and largely unknown -contributions during the COVID-19 pandemic, Tate has been credited...

Read more

Revolutionizing Med Spa Excellence: Academy of Aesthetics Offers Top-Tier Medical Director Services and Private Training for Injectors

September 30, 2024 10:00 AM

Academy of Aesthetics, led by Megan Davies FNP-BC, CANS, announces the launch of its Medical Director services and Private Training programs for aesthetic injectors. With over a decade of industry experience, Megan Davies is setting a new standard for professional development and compliance in medical aesthetics.SCOTTSDALE, AZ / ACCESSWIRE / September 30, 2024 / Academy of Aesthetics offers specialized Medical Director services for Registered...

Read more

Change in Number of Shares and Votes in Ascelia Pharma AB

September 30, 2024 9:45 AM

MALMÖ, SWEDEN / ACCESSWIRE / September 30, 2024 / Ascelia Pharma (STO:ACE)During September, the registered number of shares and votes in Ascelia Pharma AB ("Ascelia Pharma") has increased due to the rights issue of units resolved by the Board of Directors on 10 July 2024 and approved by the Extraordinary General Meeting on 14 August 2024. As of 30 September 2024, the total number of shares in Ascelia Pharma amounts to 97,193,153 shares, whereof...

Read more

AGC Biologics Strengthens Portfolio with Latest FDA Commercial Approval at Copenhagen Facility

September 30, 2024 9:45 AM

COPENHAGEN, DENMARK / ACCESSWIRE / September 30, 2024 / AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced the newest milestone at its Copenhagen Campus, a U.S. Food and Drug Administration (FDA) commercial approval for a biosimilar indicated for psoriasis, psoriatic arthritis, Crohn's disease and ulcerative colitis. This is the latest commercial biosimilar approval for...

Read more

Hypha Labs, Inc. Reveals First Functional Mushroom Ingredient Array for Home and Commercial Production

September 30, 2024 9:30 AM

First Generation ‘MicroPearls Pro™'and "MicroPearls ProX™" Will Support Largest Mushroom Ingredient CategoriesLAS VEGAS, NV / ACCESSWIRE / September 30, 2024 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, is pleased to announce the first Functional Mushroom ingredient array for its first generation products, the MicroPearls Pro™, designed for home use and The...

Read more

Study Indicates Significant Radiation Reduction for Breast Cancer Patients

September 30, 2024 9:00 AM

Lumpectomy Patients Received VeraForm® Marker and APBI Therapy for Breast Cancer TreatmentSAN FRANCISCO, CA / ACCESSWIRE / September 30, 2024 / A recent study accepted by the American Society of Radiation Oncology (ASTRO) for their annual meeting in Washington D.C. demonstrates a significant reduction in radiation Planning Target Volume involving patients who received Breast Conserving Surgery (lumpectomy), a VeraForm® marker for cavity...

Read more

Axis Integrated Mental Health Recognized as Top Startup for Advancing Collaborative Mental Health Care

September 30, 2024 9:00 AM

Top Startup Award Marks a Year of Milestones for Colorado's Leading Mental Health InnovatorWESTMINSTER, CO / ACCESSWIRE / September 30, 2024 / Axis Integrated Mental Health is thrilled to announce its recognition as Top Startup of the Year by ColoradoBiz Magazine. The award honors Axis' innovative approach in transforming mental health care through strategic partnerships with healthcare providers across Colorado.ColoradoBiz Top Startup of the...

Read more

Modular Medical to Present at the Lytham Partners Fall 2024 Investor Conference on October 1

September 30, 2024 8:00 AM

Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" thanks to its user-friendly and affordable design, will participate in a webcasted presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2024 Investor Conference, taking place virtually on October 1,...

Read more

Moderna Announces First Participant Dosed in Pivotal Phase 3 Trial of Investigational mRNA Norovirus Vaccine, mRNA-1403

September 30, 2024 7:00 AM

Moderna, Inc. (NASDAQ:MRNA) today announced that the first participant in the U.S. has been dosed in the Nova 301 Trial, a pivotal Phase 3 randomized clinical trial evaluating the efficacy, safety, and immunogenicity of an investigational norovirus vaccine, mRNA-1403. Global recruitment for the Nova 301 trial has also begun."Norovirus is a significant public health concern that affects millions of people worldwide each year, leading to severe...

Read more

NanoViricides, Inc. Has Filed its Annual Report: Broad-spectrum Antiviral NV-387 Progressing to Phase II Clinical Trial - Multiple Indications of NV-387 Include RSV, Influenza, MPOX/Smallpox, COVID

September 30, 2024 6:30 AM

NanoViricides, Inc. (NYSE American:NNVC ) (the "Company"), reports that it has filed its Annual Report on Form 10-K for the fiscal year ending June 30, 2024 with the Securities and Exchange Commission (SEC) on Friday, September 27, 2024. The report can be accessed at the SEC website (https://www.sec.gov/ix?doc=/Archives/edgar/data/1379006/000141057824001650/nnvc-20240630x10k.htm).We reported that, as of June 30, 2024, we had cash and cash...

Read more

Genflow Biosciences PLC Announces Half-year Report

September 30, 2024 2:00 AM

Genflow (LSE:GENF) is pleased to announce its half year results for the six-month period ended 30 June 2024.Chairman's StatementIt is with pleasure that I take this opportunity to update shareholders of Genflow Biosciences Plc ("Genflow" or the "Company") on the Company's performance during the first six months of 2024.Over the six months to 30 June 2024, the Company has made strides in its principal longevity programs: MASH (Metabolic...

Read more

IRLAB has Enrolled the Last Patient in the Phase IIb Study of Pirepemat

September 30, 2024 1:20 AM

GOTHENBURG, SWEDEN / ACCESSWIRE / September 30, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, September 30, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company that discovers and develops new treatments for Parkinson's disease, today announces that the last patient has been enrolled in the ongoing Phase IIb study of pirepemat and that a reduction in the number of falls has been observed in the overall...

Read more

T2D.com Announces That Former NFL Linebacker Alec Ogletree Has Joined the Company as a Co-Founder

September 30, 2024 12:00 AM

Alec Ogletree, former NFL Linebacker and first-round draft pick out of University of Georgia has joined Vertical Insight Corp and its subsidiary company T2D.com. Alec had an accomplished career in professional football, but his ambitions and interests outside of it are focused on making an even bigger impact off the field. Alec's interest in human healthcare might have begun early in life as many of his family members have a background within...

Read more

Quantum Biopharma Provides Corporate Update

September 27, 2024 8:06 PM

TORONTO, ON / ACCESSWIRE / September 27, 2024 / Quantum BioPharma Ltd. (formerly, FSD Pharma Inc.) (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce the following corporate updates. Option GrantThe Company announces the grant of 29,500 stock options (the "Stock Options") to certain directors,...

Read more

Diabetic Exchange USA Introduces a Better Way to Sell Diabetic Supplies

September 27, 2024 5:00 PM

Diabetic Exchange USA offers a hassle-free way to sell diabetic supplies like lancets, test strips, and continuous glucose monitors (CGMs). The company also provides the best prices for those supplies in the industry."We're not the first company to buy diabetic supplies, but we're the first one to make things simple and painless for sellers," explained Eli, the company's CEO. "We're also the first business to offer high payouts so our customers...

Read more